OVERVIEW
An investigational single molecule designed to activate GIP, GLP-1, and glucagon receptors, creating a three-pathway metabolic signaling profile.
RESEARCH CATALOG • 02
Retatrutide
10 mg
02
RESEARCH FOCUS
Multi-receptor incretin biology, glucagon signaling, energy balance, glucose metabolism, and obesity-related research.
CLASS / TYPE
Triple GIP / GLP-1 / glucagon receptor agonist
KEY PATHWAYS / TARGETS
GIPR • GLP-1R • glucagon receptor (GCGR)
RESEARCH STATUS
Investigational; clinical development is ongoing.
COMMON RESEARCH AREAS
Obesity research • metabolic disease • glucose regulation • cardiometabolic research
RESEARCH NOTE
Its defining scientific feature is simultaneous activity at three hormone receptors.
For research use only.